Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma

By Li He-cheng   Cao Dao-cheng   Liu Yi   Hou Yi-feng   Wu Jiong   Lu Jin-song   Di Gen-hong   Liu Gang   Li Fang-ming   Ou Zhou-luo   Jie Cui   Shen Zhen-zhou   Shao Zhi-ming  

Breast Cancer Research and Treatment, Vol. 88, Iss. 1, 2004-11 ,pp. : 75-85

Springer Publishing Company

Access to resources Recommend Favorite

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer

By Jonsdottir Kristin   Zhang Hui   Jhagroe Darshni   Skaland Ivar   Slewa Aida   Björkblom Benny   Coffey Eleanor   Gudlaugsson Einar   Smaaland Rune   Janssen Emiel   Baak Jan  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 229-230

Informa Healthcare

Access to resources Recommend Favorite

TP53 Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast Cancer

By Overgaard Jens   Yilmaz Mette   Guldberg Per   Hansen Lise Lotte   Alsner Jan  

Acta Oncologica, Vol. 39, Iss. 3, 2000-10 ,pp. : 327-333

Informa Healthcare

Access to resources Recommend Favorite

Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer

By Wang Bin  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 339-343

Springer Publishing Company

Access to resources Recommend Favorite